Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News DANAHER CORPORATION DHR.49

Primary Symbol: DHR Alternate Symbol(s):  DHR.P.A | DHR.26 | DHR.28 | DHR.31 | DHR.39 | DHR.24 | DHR.30

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process,...

Recent & Breaking News (NYSE:DHR)

Danaher to Present at Evercore ISI HealthCONx Conference

PR Newswire 10 days ago

Cepheid Launches Multiplex Vaginal Panel (MVP) to Support More Accurate Women's Health Diagnosis in U.S.

PR Newswire November 15, 2022

Danaher Launches Beacon Initiative and Its First Partnership Focused on Gene Therapy Innovation

PR Newswire November 10, 2022

Danaher Reports Third Quarter 2022 Results

PR Newswire October 20, 2022

Danaher Releases 2022 Sustainability Report and Announces New Greenhouse Gas Emissions Reduction Target

PR Newswire October 5, 2022

Danaher Schedules Third Quarter 2022 Earnings Conference Call

PR Newswire September 20, 2022

Danaher CEO to Comment on Financial Performance

PR Newswire September 14, 2022

Danaher Announces Intention to Separate Environmental & Applied Solutions Segment to Create an Independent, Publicly Traded Company

PR Newswire September 14, 2022

Danaher Announces Quarterly Dividends

PR Newswire September 13, 2022

Danaher to Webcast Bioprocessing Investor and Analyst Meeting at Cytiva

PR Newswire September 1, 2022

Beckman Coulter Partners with Mass General and BARDA to Identify Severe Pediatric Infections in Emergency Departments

PR Newswire July 25, 2022

Danaher Reports Second Quarter 2022 Results

PR Newswire July 21, 2022

Danaher Announces Appointment of Feroz Dewan to Danaher Board

PR Newswire June 29, 2022

Danaher Schedules Second Quarter 2022 Earnings Conference Call

PR Newswire June 21, 2022

SCIEX Launches the Next Generation of Data Independent Acquisition With Zeno SWATH DIA at ASMS 2022

Business Wire June 6, 2022

SCIEX Launches the New Cornerstone of Software Ecosystem - SCIEX OS 3.0

Business Wire June 6, 2022

Danaher Joins Bespoke Gene Therapy Consortium (BGTC) for Rare Diseases

PR Newswire May 12, 2022


PR Newswire May 10, 2022

RNA 9000 Purity and Integrity Kit Allows for Critical High-Resolution Analysis for mRNA Therapeutics

Business Wire May 9, 2022

Danaher To Present At Bank Of America Securities Health Care Conference

PR Newswire May 4, 2022